Several regulatory and technical milestones have already been reached during the DuPont Tyvek Medical Packaging Transition Project (MPTP), speakers reported during the May 7 Webcast, “Are You Ready for the DuPont Tyvek Transition?” Speakers included Roseann C. Salasin, Global Marketing Director; Bruce A. Yost, Ph.D., Global Technical Director, Thierry Wagner, Regulatory Affairs Director, Europe, Middle-East, and Africa; Mike Scholla, Global Regulatory Director; and Leslie Love, MDM Specialist.
A few weeks ago I asked a room full of designers to re-think, or “re-design” the way they work. For some of them the assignment seemed to be an odd request. I got several “What do you mean?” looks. I got a sense from even more that they never thought about it before. Design is a process that starts here and ends there, and that’s just the way it is. But “the way we work” is, in itself, a design.
Amcor Flexibles took an unconventional approach to sterile breather bags with the design of its Fortis product line, which launched in February. The bags are made with nylon film instead of polyethylene, and they are sealed with uncoated Tyvek, but without any additional film strips. Both of these features are departures from traditional breather bags, says Tara Ford, Business Development Manager at Amcor Flexibles Healthcare.
Critics always ask why billions of dollars are spent on space missions when millions are starving on “terra nostra.” But even theses critics will agree that space missions have indeed helped find solutions for some of the toughest engineering challenges.
While testing of sterile packaging produced for the DuPont Tyvek Medical Packaging Transition Project (MPTP) continues, the first round of results for pre-sterile and post sterile (at T=0) evaluations for the packages represented in the FDA-accepted transition protocol are nearing completion. As Nelson Laboratories completes testing for the 78 different combinations (also called cells) included in protocol, the testing lab is providing data to DuPont for drafting summary reports to industry.
Containing packaging costs and even reducing them is most likely on more than a few to-do lists this year. In a recent survey PMP News and sister publication Packaging Digest conducted on packaging sustainability, managing costs and addressing regulatory requirements were tied as the top business factors impacting pharmaceutical and medical device company strategies. (For more on this survey, conducted along with the Sustainable Packaging Coalition, please click here.)
Packaging considerations should be made early during the product development process, advises members of the Sterilization Packaging Manufacturers Council (SPMC) of the Flexible Packaging Association. Members of the SPMC’s Technical Group spoke during the Webcast, “Sterilization: A Sterile Packaging Perspective,” covering the impacts that different sterilization methods have on medical packaging materials and what to consider when developing such packaging.
Presentation proposals are now being accepted for HealthPack USA, which will return to Albuquerque on March 11-13, 2014.
Event organizers are interested in presentations on the following topics:
DuPont Medical & Pharmaceutical Protection has achieved several milestones in its Tyvek Medical Packaging Transition Project (MPTP), having completed half of its eight-phase project. Speakers from DuPont provided medical device manufacturers with regulatory updates as well as material testing data results during a recent PMP News Webcast and at a lunchtime meeting at MD&M East in Philadelphia.
Oliver-Tolas Healthcare Packaging has expanded operations at three of its locations around the world. The supplier of sterile-grade packaging has acquired a 50,000 sq-ft facility adjacent to its current Feasterville, PA, location; expanded its cleanroom manufacturing space in Venray, Netherlands; and launched manufacturing in Suzhou, China.